EventsNews Cortexyme to Present at the BofA Securities 2021 Healthcare Conference on May 11, 2021 By admin | Events, News
EventsNews Cortexyme to Present at the Stifel 3rd Annual CNS Day on April 1, 2021 By admin | Events, News
EventsNews Cortexyme to Present at the Oppenheimer 31st Annual Healthcare Conference on March 16, 2021 By admin | Events, News
News Cortexyme Announces Partnership with Parkinson Study Group and Upcoming Alzheimer’s Disease Data Presentation By admin | News
NewsPress Release Cortexyme Provides Regulatory Update on Development Program for Atuzaginstat in Alzheimer’s Disease By admin | News, Press Release
NewsPress Release Cortexyme Announces Leadership Appointments to Support Advancement of Atuzaginstat and Pipeline Expansion By admin | News, Press Release
NewsPress Release Cortexyme Announces Pipeline Update and Anticipated 2021 Milestones By admin | News, Press Release
EventsPress Release Cortexyme’s Phase 2/3 GAIN Trial of Atuzaginstat (COR388) in Patients with Alzheimer’s Disease Successfully Advances Past Interim Analysis By admin | Events, Press Release
News Cortexyme Announces Third Quarter 2020 Financial Results and Provides Business Update By admin | News
EventsPress Release Cortexyme Announces Upcoming Data Presentations at November 2020 Conferences By admin | Events, Press Release
